Emyria Ltd has released a press release.
Emyria and Cann Partner to Register CBD Product
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- Emyria Adds Second Clinical Site in Perth
- Emyria adds second Emerald Clinic in Melbourne
- Emyria wins digital health monitoring grant with UWA
- FDA Position on RWE to Guide Registration
- Emyria Pursuing Registration of EMD-003 in CY2021
Later from Emyria
- $5m Placement for Drug Registration and Treatment Pipeline
- Emyria and MMA launch MDMA-assisted therapy program for PTSD
- Emyria Obtains TGA Approval for Medical Grade Monitoring App
- Emyria Data Validated, Care Model Reduces Opioids
- Emyria Advances EMD-004 Program Towards Registration
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria